BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19541379)

  • 1. Adjuvant chemoradiation versus surgery alone for adenocarcinoma of the ampulla of Vater.
    Zhou J; Hsu CC; Winter JM; Pawlik TM; Laheru D; Hughes MA; Donehower R; Wolfgang C; Akbar U; Schulick R; Cameron J; Herman JM
    Radiother Oncol; 2009 Aug; 92(2):244-8. PubMed ID: 19541379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
    Narang AK; Miller RC; Hsu CC; Bhatia S; Pawlik TM; Laheru D; Hruban RH; Zhou J; Winter JM; Haddock MG; Donohue JH; Schulick RD; Wolfgang CL; Cameron JL; Herman JM
    Radiat Oncol; 2011 Sep; 6():126. PubMed ID: 21951377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy.
    Palta M; Patel P; Broadwater G; Willett C; Pepek J; Tyler D; Zafar SY; Uronis H; Hurwitz H; White R; Czito B
    Ann Surg Oncol; 2012 May; 19(5):1535-40. PubMed ID: 22045467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater.
    Krishnan S; Rana V; Evans DB; Varadhachary G; Das P; Bhatia S; Delclos ME; Janjan NA; Wolff RA; Crane CH; Pisters PW
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):735-43. PubMed ID: 17980502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.
    Ecker BL; Vollmer CM; Behrman SW; Allegrini V; Aversa J; Ball CG; Barrows CE; Berger AC; Cagigas MN; Christein JD; Dixon E; Fisher WE; Freedman-Weiss M; Guzman-Pruneda F; Hollis RH; House MG; Kent TS; Kowalsky SJ; Malleo G; Salem RR; Salvia R; Schmidt CR; Seykora TF; Zheng R; Zureikat AH; Dickson PV
    JAMA Surg; 2019 Aug; 154(8):706-714. PubMed ID: 31141112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant radiotherapy following pancreaticoduodenectomy for ampullary adenocarcinoma improves survival in node-positive patients: a propensity score analysis.
    Kamarajah SK
    Clin Transl Oncol; 2018 Sep; 20(9):1212-1218. PubMed ID: 29497964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the role of adjuvant external beam radiotherapy on resected adenocarcinoma of the ampulla of vater.
    Miura JT; Jayakrishnan TT; Amini A; Johnston FM; Tsai S; Erickson B; Quebbeman EJ; Christians KK; Evans DB; Gamblin TC; Turaga KK
    J Gastrointest Surg; 2014 Nov; 18(11):2003-8. PubMed ID: 25159502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ampullary adenocarcinoma: Defining predictors of survival and the impact of adjuvant therapy following surgical resection for stage I disease.
    Stiles ZE; Behrman SW; Deneve JL; Glazer ES; Dong L; Wan JY; Martin MG; Dickson PV
    J Surg Oncol; 2018 Jun; 117(7):1500-1508. PubMed ID: 29518820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy for ampullary carcinomas: the Mayo Clinic experience.
    Bhatia S; Miller RC; Haddock MG; Donohue JH; Krishnan S
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):514-9. PubMed ID: 16863684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma.
    Shaib WL; Sharma R; Brutcher E; Kim S; Maithel SK; Chen Z; Kooby DA; Kauh J; Landry J; El-Rayes BF
    J Surg Oncol; 2014 May; 109(6):556-60. PubMed ID: 24338561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors and the Role of Adjuvant Treatment in Periampullary Carcinoma: a Single-Centre Experience of 95 Patients.
    Baghmar S; Agrawal N; Kumar G; Bihari C; Patidar Y; Kumar S; Chattopadhyay TK; Panda D; Arora A; Pamecha V
    J Gastrointest Cancer; 2019 Sep; 50(3):361-369. PubMed ID: 29464529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
    Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
    Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Approach to Adenocarcinoma of the Ampulla of Vater.
    Patel M; Uboha NV
    Curr Treat Options Oncol; 2021 Sep; 22(11):103. PubMed ID: 34586537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic relevance of lymph node status for patients with ampullary adenocarcinoma after radical resection followed by adjuvant treatment.
    Kwon J; Kim K; Chie EK; Kim BH; Jang JY; Kim SW; Oh DY; Bang YJ
    Eur J Surg Oncol; 2017 Sep; 43(9):1690-1696. PubMed ID: 28648977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
    Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
    J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater.
    Cloyd JM; Wang H; Overman M; Zhao J; Denbo J; Prakash L; Kim MP; Shroff R; Javle M; Varadhachary GR; Fogelman D; Wolff RA; Koay EJ; Das P; Maitra A; Aloia TA; Vauthey JN; Fleming JB; Lee JE; Katz MHG
    Ann Surg Oncol; 2017 Jul; 24(7):2031-2039. PubMed ID: 28124275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
    Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
    Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone.
    Borghero Y; Crane CH; Szklaruk J; Oyarzo M; Curley S; Pisters PW; Evans D; Abdalla EK; Thomas MB; Das P; Wistuba II; Krishnan S; Vauthey JN
    Ann Surg Oncol; 2008 Nov; 15(11):3147-56. PubMed ID: 18754070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections.
    Duffy JP; Hines OJ; Liu JH; Ko CY; Cortina G; Isacoff WH; Nguyen H; Leonardi M; Tompkins RK; Reber HA
    Arch Surg; 2003 Sep; 138(9):941-8; discussion 948-50. PubMed ID: 12963649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma.
    Hattangadi JA; Hong TS; Yeap BY; Mamon HJ
    Cancer; 2009 Aug; 115(16):3640-50. PubMed ID: 19514088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.